NANG KUANG PHARMACEUTICAL CO., LTD.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 1963-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.nangkuang.com.tw
A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers
- First Posted Date
- 2022-10-20
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05588557
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei city, Taiwan
A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340)
- First Posted Date
- 2020-08-17
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT04515953
- Locations
- 🇨🇳
Nang Kuang Pharmaceutical Co., LTD, Tainan City, Taiwan (台灣), Taiwan
Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT02074267
- Locations
- 🇨🇳
Nang Kuang Pharmaceutical Co., LTD, Tainan, Taiwan
A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02017600
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT01370876
- Locations
- 🇨🇳
Taipei Mackay Memorial Hospital, Taipei, Taiwan
A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain
- First Posted Date
- 2010-05-10
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01119924
- Locations
- 🇨🇳
Nang Kuang Pharmaceutical Co., LTD, Tainan, Xinhua Township, Taiwan
Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2011-06-09
- Lead Sponsor
- Nang Kuang Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT01108978
- Locations
- 🇨🇳
Nang Kuang Pharmaceutical Co., LTD, Tainan, Xinhua Township, Taiwan
© Copyright 2024. All Rights Reserved by MedPath